IRONWOOD PHARMACEUTICALS, INC. Variable Lease, Cost
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Variable Lease, Cost of $360.00 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2022-02-18
- IRONWOOD PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2020-06-30 was $360.00K, a 44.95% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2019-12-31 was $218.00K.
- IRONWOOD PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2019-09-30 was $654.00K.
- IRONWOOD PHARMACEUTICALS, INC. variable lease, cost for the quarter ending 2019-06-30 was $654.00K.
- IRONWOOD PHARMACEUTICALS, INC. variable lease, cost for fiscal 2019 was $1.53M.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2020-06-30 | $360.00K 10-Q · filed 2020-08-06 | $732.00K 10-Q · filed 2020-08-06 | ||
| 2019-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $872.00K derived: sum of 2 quarters · filed 2022-02-18 | $1.53M derived: sum of 3 quarters · filed 2022-02-18 | $1.53M 10-K · filed 2022-02-18 |
| 2019-09-30 | $654.00K 10-Q · filed 2020-11-05 | $1.31M derived: sum of 2 quarters · filed 2020-11-05 | $1.31M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $654.00K 10-Q · filed 2020-08-06 | $654.00K 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |